CL

Colgate Palmolive's significant EPS beat indicates strong performance in managing costs, but the stock's decline of 4.61% suggests investor concerns about future growth and market conditions. The lack of revenue data and guidance may have contributed to the negative stock reaction, as investors often look for clearer signals about a company's trajectory.